by Amanda Brahlek | Oct 24, 2025 | Clinical Pharmacology
Drugs for cytomegalovirus (CMV) infection The anti-human CMV drugs used currently target CMV replication via two distinct mechanisms. pUL54 inhibitors Ganciclovir (GCV; Cytovene) is a nucleoside analogue. It must be phosphorylated (to the nucleotide) by the viral...
by aporter@parthenonmgmt.com | Aug 25, 2025 | Clinical Pharmacology
Drug abuse is the misuse of recreational or therapeutic drugs that may lead to addiction or dependence, serious physiological injury (such as damage to kidneys, liver, heart), psychological harm (abnormal behaviour patterns, hallucinations, memory loss), or death....
by aporter@parthenonmgmt.com | Aug 25, 2025 | Clinical Pharmacology
Complementary medicine is a therapeutic approach that is used together with conventional medicine. An example might be a patient seeking help from aromatherapy to help with pain control after undergoing surgery. Alternative medicine is a therapeutic approach which is...
by aporter@parthenonmgmt.com | Aug 25, 2025 | Clinical Pharmacology
Prescribing medicines is the intervention that most doctors make to restore or preserve the health of their patients and is the major tool used by modern healthcare systems to improve public health. Prescribing also carries significant risks related to adverse drug...
by aporter@parthenonmgmt.com | Aug 25, 2025 | Clinical Pharmacology
Evidence-based prescribing can be defined as making prescribing decisions on the basis of a systematic review and critical appraisal of clinical research findings in order to provide the optimum standard of care for individual patients. In practice, individual...
by aporter@parthenonmgmt.com | Aug 25, 2025 | Clinical Pharmacology
Many medicines meet the three key regulatory requirements of quality, safety and efficacy. National formularies usually list several thousand licensed medicines and although prescribers are legally entitled to prescribe any of them it is desirable to limit the choice...
